Lactate dehydrogenase versus haemoglobin: which one is the better marker in paroxysmal nocturnal haemoglobinuria? von Brodsky, Robert A., Lee, Jong Wook, Nishimura, Jun‐ichi, Szer, Jeff

Volltext

Genetic Variants in C5 and Poor Response to Eculizumab von Nishimura, Jun-ichi, Yamamoto, Masaki, Hayashi, Shin, Ohyashiki, Kazuma, Ando, Kiyoshi, Brodsky, Andres L, Noji, Hideyoshi, Kitamura, Kunio, Eto, Tetsuya, Takahashi, Toru, Masuko, Masayoshi, Matsumoto, Takuro, Wano, Yuji, Shichishima, Tsutomu, Shibayama, Hirohiko, Hase, Masakazu, Li, Lan, Johnson, Krista, Lazarowski, Alberto, Tamburini, Paul, Inazawa, Johji, Kinoshita, Taroh, Kanakura, Yuzuru

Volltext

Successful treatment of a PNH patient non‐responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan) von Schols, Saskia, Nunn, Miles A., Mackie, Ian, Weston‐Davies, Wynne, Nishimura, Jun‐ichi, Kanakura, Yuzuru, Blijlevens, Nicole, Muus, Petra, Langemeijer, Saskia

Volltext

Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study von Nishimura, Jun‐ichi, Usuki, Kensuke, Ramos, Julia, Ichikawa, Satoshi, Buri, Muriel, Kiialainen, Anna, Sostelly, Alexandre, Peffault de Latour, Régis, Paz‐Priel, Ido, Röth, Alexander

Volltext

A longitudinal analysis of paroxysmal nocturnal haemoglobinuria‐type cells in patients with bone marrow failure: Results of a prospective multi‐centre study in Japan von Ishiyama, Ken, Yonemura, Yuji, Kawaguchi, Tatsuya, Hosokawa, Kohei, Sugimori, Chiharu, Ueda, Yasutaka, Takamori, Hiroyuki, Obara, Naoshi, Noji, Hideyoshi, Shirasugi, Yukari, Ando, Kiyoshi, Shichishima, Tsutomu, Ninomiya, Haruhiko, Chiba, Shigeru, Nishimura, Jun‐ichi, Kanakura, Yuzuru, Nakao, Shinji

Volltext

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria von Röth, Alexander, Nishimura, Jun-ichi, Nagy, Zsolt, Gaàl-Weisinger, Julia, Panse, Jens, Yoon, Sung-Soo, Egyed, Miklos, Ichikawa, Satoshi, Ito, Yoshikazu, Kim, Jin Seok, Ninomiya, Haruhiko, Schrezenmeier, Hubert, Sica, Simona, Usuki, Kensuke, Sicre de Fontbrune, Flore, Soret, Juliette, Sostelly, Alexandre, Higginson, James, Dieckmann, Andreas, Gentile, Brittany, Anzures-Cabrera, Judith, Shinomiya, Kenji, Jordan, Gregor, Biedzka-Sarek, Marta, Klughammer, Barbara, Jahreis, Angelika, Bucher, Christoph, Peffault de Latour, Régis

Volltext

Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial von Röth, Alexander, Ichikawa, Satoshi, Ito, Yoshikazu, Kim, Jin Seok, Nagy, Zsolt, Obara, Naoshi, Panse, Jens, Schrezenmeier, Hubert, Sica, Simona, Soret, Juliette, Usuki, Kensuke, Yoon, Sung‐Soo, Balachandran, Nadiesh, Buri, Muriel, Lundberg, Pontus, Patel, Himika, Shinomiya, Kenji, Sostelly, Alexandre, Nishimura, Jun‐ichi

Volltext

Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria: Expert consensus von Röth, Alexander, Maciejewski, Jaroslaw, Nishimura, Jun‐Ichi, Jain, Deepak, Weitz, Jeffrey I.

Volltext

Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition von Röth, Alexander, He, Guangsheng, Tong, Hongyan, Lin, Zenghua, Wang, Xiaoqin, Chai‐Adisaksopha, Chatree, Lee, Je‐Hwan, Brodsky, Andres, Hantaweepant, Chattree, Dumagay, Teresita E., Demichelis‐Gómez, Roberta, Rojnuckarin, Ponlapat, Sun, Jing, Höglund, Martin, Jang, Jun Ho, Gaya, Anna, Silva, Fernando, Obara, Naoshi, Kelly, Richard J., Beveridge, Leigh, Buatois, Simon, Chebon, Sammy, Gentile, Brittany, Lundberg, Pontus, Sreckovic, Sasha, Nishimura, Jun‐ichi, Risitano, Antonio, Han, Bing

Volltext

Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan von Ikezoe, Takayuki, Noji, Hideyoshi, Ueda, Yasutaka, Kanda, Yoshinobu, Okamoto, Shinichiro, Usuki, Kensuke, Matsuda, Takahisa, Akiyama, Hirozumi, Shimono, Akihiko, Yonemura, Yuji, Kawaguchi, Tatsuya, Chiba, Shigeru, Kanakura, Yuzuru, Nishimura, Jun‑ichi, Ninomiya, Haruhiko, Obara, Naoshi

Volltext

Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan von Kamesaki, Toyomi, Nishimura, Jun-ichi, Wada, Hideho, Yu, Eric, Tsao, Elisa, Morales, Jaime, Kanakura, Yuzuru

Volltext

Mitigating Drug–Target–Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 Inhibitors von Nishimura, Jun‐ichi, Soubret, Antoine, Arase, Noriko, Buatois, Simon, Hotta, Masaki, Charoin, Jean‐Eric, Ito, Yoshikazu, Sreckovic, Sasha, Takamori, Hiroyuki, Bucher, Christoph, Ueda, Yasutaka, Hernández‐Sánchez, Jules, Gotanda, Keisuke, Jordan, Gregor, Shinomiya, Kenji, Ramos, Julia, Kim, Jin Seok, Panse, Jens, Latour, Régis Peffault, Röth, Alexander, Morii, Eiichi, Schrezenmeier, Hubert, Isaka, Yoshitaka, Sica, Simona, Kanakura, Yuzuru, Yoon, Sung‐Soo, Kinoshita, Taroh, Paz‐Priel, Ido, Sostelly, Alexandre

Volltext

Deactivation mechanism of MFI-type zeolites by coke formation during n-hexane cracking von Nakasaka, Yuta, Nishimura, Jun-ichi, Tago, Teruoki, Masuda, Takao

Volltext

Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria von Nishimura, Jun-Ichi, Ando, Kiyoshi, Masuko, Masayoshi, Noji, Hideyoshi, Ito, Yoshikazu, Mayer, Jiri, Griskevicius, Laimonas, Bucher, Christoph, Müllershausen, Florian, Gergely, Peter, Rozenberg, Izabela, Schubart, Anna, Chawla, Raghav, Rondeau, Jean-Michel, Roguska, Michael, Splawski, Igor, Keating, Mark T, Johnson, Leslie, Danekula, Rambabu, Bagger, Morten, Watanabe, Yoko, Haraldsson, Börje, Kanakura, Yuzuru

Volltext

Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports von Ito, Yu, Awano, Nobuyasu, Uchiyama, Fumiya, Inomata, Minoru, Kuse, Naoyuki, Tone, Mari, Takada, Kohei, Fujimoto, Kazushi, Muto, Yutaka, Sagisaka, Shogo, Maki, Kenro, Yamashita, Ryuta, Harada, Akinori, Nishimura, Jun-ichi, Hayashi, Munehiro, Izumo, Takehiro

Volltext

Donor stem cell‐derived paroxysmal nocturnal hemoglobinuria after umbilical cord blood transplantation von Nakaya, Yosuke, Nakao, Takafumi, Ueda, Yasutaka, Takamori, Hiroyuki, Nishimura, Jun‐Ichi, Tatsumi, Naoko, Tsutsumi, Minako, Yoshida, Masahiro, Yoshimura, Takuro, Hayashi, Yoshiki, Yamane, Takahisa

Volltext

The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria von Kulasekararaj, Austin G., Brodsky, Robert A., Nishimura, Jun-ichi, Patriquin, Christopher J., Schrezenmeier, Hubert

Volltext

The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with b... von Hosokawa, Kohei, Ishiyama, Ken, Ikemoto, Toshiyuki, Sugimori, Chiharu, Noji, Hideyoshi, Shichishima, Tsutomu, Obara, Naoshi, Chiba, Shigeru, Ninomiya, Haruhiko, Nguyen, Mai Anh Thi, Shirasugi, Yukari, Nakamura, Yoshihiko, Ando, Kiyoshi, Ueda, Yasutaka, Yonemura, Yuji, Kawaguchi, Tatsuya, Nishimura, Jun-ichi, Kanakura, Yuzuru, Nakao, Shinji

Volltext

Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients von Ishiyama, Ken, Nakao, Shinji, Usuki, Kensuke, Yonemura, Yuji, Ikezoe, Takayuki, Uchiyama, Michihiro, Mori, Yasuo, Fukuda, Tetsuya, Okada, Masaya, Fujiwara, Shin-ichiro, Noji, Hideyoshi, Rottinghaus, Scott, Aguzzi, Rasha, Yokosawa, Jun, Nishimura, Jun-Ichi, Kanakura, Yuzuru, Okamoto, Shinichiro

Volltext

Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review von Miyasaka, Naoyuki, Miura, Osamu, Kawaguchi, Tatsuya, Arima, Nobuyoshi, Morishita, Eriko, Usuki, Kensuke, Morita, Yasuyoshi, Nishiwaki, Kaichi, Ninomiya, Haruhiko, Gotoh, Akihiko, Imashuku, Shinsaku, Urabe, Akio, Shichishima, Tsutomu, Nishimura, Jun-ichi, Kanakura, Yuzuru

Volltext